278 related articles for article (PubMed ID: 32321767)
1. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
Nunes de Arruda F; da Costa S; Bonadio R; Dornellas A; Pereira D; de Bock GH; Del Pilar Estevez Diz M
Int J Gynecol Cancer; 2020 Jun; 30(6):749-756. PubMed ID: 32321767
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
[TBL] [Abstract][Full Text] [Related]
4. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies.
Duenas-Gonzalez A; Lopez-Graniel C; Gonzalez-Enciso A; Mohar A; Rivera L; Mota A; Guadarrama R; Chanona G; De La Garza J
Ann Oncol; 2002 Aug; 13(8):1212-9. PubMed ID: 12181244
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
Liu B; Li L; Wang M; Wei L; Li J; Zou W; Lv Y; Zhang H; Liu S
Gynecol Oncol; 2019 Sep; 154(3):583-589. PubMed ID: 31307665
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
de Azevedo CRAS; Thuler LCS; de Mello MJG; de Oliveira Lima JT; da Fonte ALF; Fontão DFS; Carneiro VCG; Chang TMC; Ferreira CG
Gynecol Oncol; 2017 Sep; 146(3):560-565. PubMed ID: 28709705
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.
Phippen NT; Leath CA; Chino JP; Jewell EL; Havrilesky LJ; Barnett JC
Gynecol Oncol; 2012 Nov; 127(2):267-72. PubMed ID: 22892361
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.
Tangjitgamol S; Tharavichitkul E; Tovanabutra C; Rongsriyam K; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara A; Hanprasertpong J; Chomprasert K; Wanglikitkoon S; Atjimakul T; Pariyawateekul P; Katanyoo K; Tanprasert P; Janweerachai W; Sangthawan D; Khunnarong J; Chottetanaprasith T; Supawattanabodee B; Lertsanguansinchai P; Srisomboon J; Isaranuwatchai W; Lorvidhaya V
J Gynecol Oncol; 2019 Jul; 30(4):e82. PubMed ID: 31074236
[TBL] [Abstract][Full Text] [Related]
10. Long-term Quality of Life and Sexual Function After Neoadjuvant Chemotherapy and Radical Surgery for Locally Advanced Cervical Cancer.
Palaia I; Santangelo G; Caruso G; Perniola G; Tibaldi V; Muzii L; Benedetti Panici P; Di Donato V
J Sex Med; 2022 Apr; 19(4):613-619. PubMed ID: 35227622
[TBL] [Abstract][Full Text] [Related]
11. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
Wang CC; Chou HH; Yang LY; Lin H; Liou WS; Tseng CW; Liu FY; Liou JD; Huang KG; Huang HJ; Huang EY; Chen CH; Chang TC; Chang CJ; Hong JH; Lai CH
Gynecol Oncol; 2015 Jun; 137(3):462-7. PubMed ID: 25827291
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.
Li K; Chen J; Hu Y; Wang YZ; Shen Y; Chen G; Peng W; Fang Z; Xia B; Chen X; Song K; Wang Y; Zou D; Wang YC; Han Y; Feng X; Yuan J; Guo S; Meng X; Feng C; Chen Y; Yang J; Fan J; Wang J; Ai J; Ma D; Sun C
Lancet Oncol; 2024 Jan; 25(1):76-85. PubMed ID: 38048802
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer.
Gargiulo P; Arenare L; Pisano C; Cecere SC; Falivene S; Greggi S; Tambaro R; Facchini G; De Palma G; Scaffa C; Della Pepa C; Pignata S; Di Napoli M
Oncology; 2016; 90(1):29-35. PubMed ID: 26473609
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial.
Tovanabutra C; Asakij T; Rongsriyam K; Tangjitgamol S; Tharavichitkul E; Sukhaboon J; Kridakara LCA; Paengchit K; Khunnarong J; Atjimakul T; Pariyawateekul P; Tanprasert P; Tungkasamit T; Lorvidhaya V
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2977-2985. PubMed ID: 34582670
[TBL] [Abstract][Full Text] [Related]
16. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
17. Is the progression free survival advantage of concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in patients with advanced cervical cancer worth the additional cost? A cost-effectiveness analysis.
Smith B; Cohn DE; Clements A; Tierney BJ; Straughn JM
Gynecol Oncol; 2013 Sep; 130(3):416-20. PubMed ID: 23718933
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.
Serrano PE; Herman JM; Griffith KA; Zalupski MM; Kim EJ; Bekaii-Saab TS; Ben-Josef E; Dawson LA; Ringash J; Wei AC
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):270-7. PubMed ID: 25104069
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]